BURKE RICHARD T 4
4 · UNITEDHEALTH GROUP INC · Filed Mar 24, 2022
Insider Transaction Report
Form 4
BURKE RICHARD T
Director
Transactions
- Award
Common Stock
2022-03-22+77→ 150,387 total - Sale
Common Stock
2022-03-23$505.67/sh−3,000$1,517,001→ 1,225,500 total(indirect: By Partnership) - Sale
Common Stock
2022-03-24$508.80/sh−3,000$1,526,400→ 1,222,500 total(indirect: By Partnership) - Sale
Common Stock
2022-03-22$511.14/sh−4,000$2,044,568→ 1,228,500 total(indirect: By Partnership)
Footnotes (4)
- [F1]Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.
- [F2]This transaction was executed in multiple trades ranging from $511.09 to $511.25 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected.
- [F3]This transaction was executed in multiple trades ranging from $505.50 to $506.00 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected.
- [F4]This transaction was executed in multiple trades ranging from $507.63 to $509.53 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected.